ClassID:

170462

G01N2333/635 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Hormones Parathyroid hormone (parathormone); Parathyroid hormone-related peptides

Recent Application in this class:
#1
20260133179
2026-05-14

METHODS FOR DETECTING NEUTRALIZING ANTIBODIES TO PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHRP) ANALOG

#2
20260016463
2026-01-15

METHODS FOR DETECTING NEUTRALIZING ANTIBODIES TO PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHRP) ANALOG

#3
20250298006
2025-09-25

METHODS FOR DETECTING NEUTRALIZING ANTIBODIES TO PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHRP)

#4
20240319180
2024-09-26

DEVICES AND METHODS FOR DIAGNOSISING THYROID MEDICAL CONDITIONS

#5
20240158535
2024-05-16

PARATHYROID HORMONE RECEPTOR 1(PTH1R) ANTIBODIES AND USES THEREOF

#6
20240110899
2024-04-04

METHODS FOR DETECTING CHROMOGRANIN A BY MASS SPECTROMETRY

#7
20230296632
2023-09-21

RAPID PARATHORMONE IDENTIFICATION TEST KIT

#8
20230273187
2023-08-31

METHODS FOR DETECTING NEUTRALIZING ANTIBODIES TO PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHRP) ANALOG

#9
20220404358
2022-12-22

Antigen analogue for calibration of immunometric diagnostic assays

#10
20220205978
2022-06-30

Methods for detecting neutralizing antibodies to parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) analog

#11
20220187324
2022-06-16

MULTIPLEXED DIAGNOSTIC TO RECOGNIZE CONCENTRATIONS OF RELATED PROTEINS AND PEPTIDES

#12
20220163494
2022-05-26

Methods for detecting chromogranin a by mass spectrometry

#13
20210389300
2021-12-16

Methods for detecting neutralizing antibodies to parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHRP) analog

#14
20210072264
2021-03-11

Use of 1,25-Dihydroxyvitamin D Values in Ratio with PTH as a Prognostic Biomarker

#15
20200371118
2020-11-26

BIOMARKER PREDICTING CORONARY ARTERY DISEASES

#16
20200317817
2020-10-08

Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof

#17
20200200772
2020-06-25

Multiplexed diagnostic to recognize concentrations of related proteins and peptides

#18
20190361040
2019-11-28

High Sensitivity Measurement of Parathyroid Hormone Related Peptide Using LC-MS/MS and Associated Method

#19
20190285594
2019-09-19

Methods for detecting chromogranin a by mass spectrometry

#20
20180030154
2018-02-01

Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof

#21
20170333522
2017-11-23

EXPRESSION AND FUNCTION OF GPR64/ADGRG2 IN ENDOCRINE SYSTEMS AND METHODS TO TARGET IT THERAPEUTICALLY

#22
20170322230
2017-11-09

Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarker

#23
20170307629
2017-10-26

Method of identifying risk for thyroid disorder

#24
20160327577
2016-11-10

High sensitivity measurement of parathyroid hormone-related peptide using LC-MS/MS and associated methods

#25
20160195552
2016-07-07

Multiplexed diagnostic to recognize concentrations of related proteins and peptides

#26
20160025748
2016-01-28

Non-oxidized, biological active parathyroid hormone determines mortality in hemodialysis patients

#27
20150038595
2015-02-05

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

#28
20150017738
2015-01-15

Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress

#29
20130095507
2013-04-18

Method of identifying risk for thyroid disorder

#30
20110256557
2011-10-20

IDENTIFYING PARATHYROID HORMONE AGONISTS AND ANTAGONISTS

#31
20110178015
2011-07-21

METHODS OF TREATMENT USING BIASED LIGANDS FOR RECEPTORS SUCH AS THE PTH RECEPTOR

#32
20110003311
2011-01-06

DIAGNOSIS SYSTEM FOR DETERMINING THE BIOLOGICALLY EFFECTIVE PARATHYROID HORMONE ACTIVITY IN A SAMPLE

#33
20100261199
2010-10-14

Assay for the detection of phosphorylated PTH

#34
20100150909
2010-06-17

PTHrP-DERIVED MODULATORS OF SMOOTH MUSCLE PROLIFERATION

#35
20100136587
2010-06-03

Method of Identifying Risk for Thyroid Disorder

#36
20100021496
2010-01-28

METHODS, KITS, AND ANTIBODIES FOR QUANTITATIVE DETERMINATION OF PARATHYROID HORMONE MOLECULES WITH INTACT C-TERMINUS

#37
20090142773
2009-06-04

Methods and controls for monitoring assay quality and accuracy in parathyroid hormone measurement

#38
20090023655
2009-01-22

Biased Ligands for Receptors Such as the PTH Receptor

#39
20080108086
2008-05-08

Parathyroid hormone antagonists and uses thereof

#40
20070141717
2007-06-21

Dual standard curve immunoassay

#41
20070098726
2007-05-03

Methods of making and using antibodies directed to parathyroid hormone

#42
20060286107
2006-12-21

Parathyroid hormone antibodies and related methods

#43
20060211054
2006-09-21

Method for determining effective parathormone activity in a sample

#44
20060089388
2006-04-27

Use of parathyroid hormone-related protein (PTHrP) in the diagnosis and treatment of chronic lung disease and other pathologies

#45
20060068444
2006-03-30

Compositions and methods for detecting cyclic analogs of hPTH

#46
20060035282
2006-02-16

Assessing risk for kidney stones using parathyroid hormone agonist and antagonist

#47
20060024772
2006-02-02

Parathyroid hormone antibodies and related methods

#48
20050261183
2005-11-24

PTHrP-derived modulators of smooth muscle proliferation

#49
20050255537
2005-11-17

Method for monitoring treatment with a parathyroid hormone

#50
20050215606
2005-09-29

Use of parathyroid hormone-related protein(PTHRP) in the diagnosis and treatment of chronic lung disease and other pathologies

#51
20050069952
2005-03-31

Methods and controls for monitoring assay quality and accuracy in parathyroid hormone measurement

#52
20050032698
2005-02-10

Stabilized formulation of parathyroid hormone

#53
20050026833
2005-02-03

PSP-94: use for treatment of hypercalcemia and bone metastasis

#54
20050003493
2005-01-06

Parathyroid hormone antibodies and related methods